Loading
Latest filing published 14 Feb 2023 for Comera Life Sciences Holdings, Inc., €24k.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Sirshendu Roopom Banerjee in Comera Life Sciences Holdings, Inc. We count 2 filings, every one of them for a trade on 4 January 2023.
No open-market sale appears; the market trades are 1 purchase worth €24k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant.
On 14 February 2023 came the latest disclosure, an open-market purchase for €24k in Comera Life Sciences Holdings, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations